Related Experiment Video
Updated: Jul 18, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
Detection Rate, Genetic Polymorphism, Viral Load, Persistent Infection Capacity, and Pathogenicity of Human
Zuyi Chen1,2, Qichen Cheng1,2, Xuejiao Mu1,2
1Department of Laboratory Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Abstract:
Human papillomavirus type 58 (HPV58) poses a substantial burden in Asia; however, the interplay between its genetic variations, viral load, and clinical outcomes remains incompletely characterized. Therefore, we investigated HPV58 detection rates and E6/E7 allele frequency trends, and analyzed the positive selection, viral load, pathogenicity, and persistent infection capacity associated with specific genotypes/mutations using 239 743 exfoliated cervical cell samples. Our results show a gradual increase in HPV58 detection rates over time. Allele replacement occurs slowly, with significant changes manifesting after long-term accumulation. The E6 A388C(K93N) + E7 prototype enhanced short-term persistent infection capacity without increasing high-grade lesion pathogenicity, and its frequency increased. Conversely, E7 C632T (T20I) and G760A (G63S) mutations enhanced high-grade lesion pathogenicity, whereas G761A (G63D) reduced pathogenicity. HPV58 improves adaptive ability by increasing the persistent infection capacity without increasing the risk of high-grade lesions. High viral load was positively correlated with both pathogenicity and persistent infection capacity, suggesting its potential as a risk factor for predicting disease progression in HPV58 screening. No correlation was observed between HPV58 viral load and specific gene mutations/genotypes, indicating that alternative mechanisms likely drive allele replacement. This study provides insights to optimize HPV58 screening strategies and deepen understanding of its evolutionary dynamics.
More Related Videos
10:26RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
Published on: March 11, 2014
11:19Pairwise Growth Competition Assay for Determining the Replication Fitness of Human Immunodeficiency Viruses
Published on: May 4, 2015